Page 18 - ARNM-3-1

Advances in Radiotherapy
& Nuclear Medicine Diagnostics gude of biliary tract cancer

simultaneously. As diagnostic and therapeutic strategies radiomics models that can be applied to images obtained
continue to advance, the depth and scope of information using different protocols. Radiomics is widely used in the
provided by gene panel testing expand, leading to a more diagnostic, prognostic, and predictive evaluation of CCA,
precise and effective integration of genetic data into patient offering valuable insights into clinical indicators that can
care. 109 be measured or predicted. 114,115
Typically, the amount of DNA required for a gene panel 3. Summary
test ranges from 10 to 500 ng, with the proportion of tumor
cells in the sample playing a crucial role in maintaining As mentioned earlier, bile duct cancer rarely produces
the accuracy and quality of the test results. Ensuring an early symptoms, which is why it is frequently diagnosed
17
adequate percentage of tumor cells is essential for reliable at an advanced stage. The disease is commonly identified
genomic analysis and mutation detection. 110 late, primarily due to non-specific symptoms. 116
In clinical practice, tumor panel assays detect drug- Early diagnosis and timely treatment of CCA are
targetable mutations in approximately 10 – 15% of essential for improving treatment outcomes in patients.
pancreatic cancers and 40 – 50% of CCAs. As a result, the Early diagnostic methods and recognition of symptoms
use of multigene tumor NGS is strongly recommended for preceding these aggressive tumors are invaluable. It is
identifying actionable mutations in CCA, enabling more worth mentioning that non-specific symptoms (e.g.,
personalized and targeted treatment approaches. general weakness, lack of appetite, nausea, or abdominal
pain) can prolong the diagnostic process for an extended
Radiomics is currently considered a distinct branch period. 89
of science focused on developing methods for analyzing
diagnostic images (from MRI, CT, or nuclear medicine) to Symptoms attributed to bile duct cancer may also
better characterize pathological changes. These methods be indicative of other conditions. For example, upper
rely on complex computer algorithms. 111 abdominal pain can be caused by various factors and does
not necessarily point to bile duct cancer. Consequently, an
Radiomics can be used to detect tissue characteristics, increasing number of patients seek medical attention only
particularly in evaluating variations such as shape or when the disease is already in an advanced stage. Due to
heterogeneity during treatment or surveillance. In these factors, early diagnosis of bile duct cancer is rare, and
oncology, the assessment of tissue heterogeneity is of the prognosis often depends on the speed of diagnosis and
particular interest, as genomic analyses have shown that the the initiation of treatment. Therefore, it is important that
degree of tumor heterogeneity is a prognostic determinant individuals in high-risk groups undergo regular check-ups. 117
of survival and a challenge to cancer control.
Improving early diagnosis remains a key area for
Recent studies have demonstrated the potential benefits development. One of the major challenges is the late
of radiomics in non-invasive prediction of pathological detection of bile duct cancer. The future direction for
type and long-term survival in patients undergoing progress lies in the development of more effective early
resectable treatment. 112 diagnostic methods. Innovative improvements in imaging

The combination of radiomics with artificial intelligence techniques, including diagnostics based on tumor markers,
(AI) is another example of how new technologies are are also being explored. 118
being applied in diagnostics. AI refers to systems that Doctors report that in 8 out of 10 cases, bile duct cancer
can accurately derive results and conclusions from large is diagnosed too late and is often found at an advanced,
datasets using advanced computational algorithms. It inoperable stage.
encompasses various learning algorithms, including In the case of HCC, the US is highly specific but lacks
machine learning and, more recently, deep learning. 113
sufficient sensitivity to detect HCC in many patients
Radiomics can be applied to a range of imaging with liver cirrhosis, which limits its effectiveness in
techniques, including CT, MRI, PET, X-ray, and ultrasound. surveillance programs. The diagnostic performance of
There are numerous acquisition techniques in use today, CT is comparable, while MRI offers greater sensitivity.
and the choice of method can significantly impact However, the accuracy of ultrasound, spiral CT, and MRI
radiomics analyses. Differences in acquisition and image in diagnosing HCC in patients with chronic liver disease
processing can lead to inconsistent results in radiomics has not been systematically evaluated. It is estimated that
analyses of independent datasets, which represents one MRI has a sensitivity of 81% and specificity of 85%, which
of the primary challenges in the field. The main goal is higher than that of ultrasound but lower than that of
of radiomics is to identify the most stable and accurate CT. These findings highlight the individualized nature

Volume 3 Issue 1 (2025) 10 doi: 10.36922/arnm.4557